Old Web
English
Sign In
Acemap
>
Paper
>
Alternate-Day Dosing of Caplacizumab for Immune-Mediated Thrombotic Thrombocytopenic Purpura
Alternate-Day Dosing of Caplacizumab for Immune-Mediated Thrombotic Thrombocytopenic Purpura
2021
Lucas Kühne
Dennis A. Eichenauer
Paul Knöbl
Linus A. Völker
Jessica Kaufeld
Ralph Wendt
Holger Hägele
Thomas Osterholt
Marcus Bieringer
Veronika Buxhofer-Ausch
Jan Menne
Ulf Schoenermarck
Paul T. Brinkkoetter
Keywords:
Immunology
Dosing
Caplacizumab
Medicine
Immune system
Thrombotic thrombocytopenic purpura
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]